Celcuity Inc.

NasdaqCM:CELC Rapporto sulle azioni

Cap. di mercato: US$489.7m

Celcuity Gestione

Gestione criteri di controllo 4/4

Celcuity Il CEO è Brian Sullivan, nominato in Jan2012, e ha un mandato di 12.83 anni. la retribuzione annua totale è $ 1.74M, composta da 12.1% di stipendio e 87.9% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 8.12% delle azioni della società, per un valore di $ 39.79M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.8 anni e 9.3 anni.

Informazioni chiave

Brian Sullivan

Amministratore delegato

US$1.7m

Compenso totale

Percentuale dello stipendio del CEO12.1%
Mandato del CEO12.8yrs
Proprietà del CEO8.1%
Durata media del management3.8yrs
Durata media del Consiglio di amministrazione9.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Celcuity: Breast Cancer Drug Developer With Upcoming Catalysts

Nov 06

Is Celcuity (NASDAQ:CELC) Using Too Much Debt?

Aug 31
Is Celcuity (NASDAQ:CELC) Using Too Much Debt?

Celcuity: Flying A Phase 3 Trial Right Under Your Nose

Jul 05

Does Celcuity (NASDAQ:CELC) Have A Healthy Balance Sheet?

May 08
Does Celcuity (NASDAQ:CELC) Have A Healthy Balance Sheet?

Is Celcuity (NASDAQ:CELC) Using Too Much Debt?

Jul 04
Is Celcuity (NASDAQ:CELC) Using Too Much Debt?

Is Celcuity (NASDAQ:CELC) A Risky Investment?

Sep 13
Is Celcuity (NASDAQ:CELC) A Risky Investment?

Celcuity rises after hours on FDA Breakthrough Therapy nod for its breast cancer treatment

Jul 18

Is Celcuity (NASDAQ:CELC) A Risky Investment?

Jan 27
Is Celcuity (NASDAQ:CELC) A Risky Investment?

Health Check: How Prudently Does Celcuity (NASDAQ:CELC) Use Debt?

Sep 21
Health Check: How Prudently Does Celcuity (NASDAQ:CELC) Use Debt?

Celcuity: Nipping The Oncogenic Bud

Jul 08

What You Need To Know About Celcuity Inc.'s (NASDAQ:CELC) Investor Composition

Mar 14
What You Need To Know About Celcuity Inc.'s (NASDAQ:CELC) Investor Composition

We're Hopeful That Celcuity (NASDAQ:CELC) Will Use Its Cash Wisely

Jan 20
We're Hopeful That Celcuity (NASDAQ:CELC) Will Use Its Cash Wisely

Celcuity inks clinical trial pact with Massachusetts General Hospital and Puma Technologies

Dec 23

Could The Celcuity Inc. (NASDAQ:CELC) Ownership Structure Tell Us Something Useful?

Nov 29
Could The Celcuity Inc. (NASDAQ:CELC) Ownership Structure Tell Us Something Useful?

Celcuity EPS beats by $0.03

Nov 09

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Brian Sullivan rispetto agli utili di Celcuity?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

-US$94m

Jun 30 2024n/an/a

-US$83m

Mar 31 2024n/an/a

-US$73m

Dec 31 2023US$2mUS$210k

-US$64m

Sep 30 2023n/an/a

-US$57m

Jun 30 2023n/an/a

-US$49m

Mar 31 2023n/an/a

-US$45m

Dec 31 2022US$2mUS$106k

-US$41m

Sep 30 2022n/an/a

-US$36m

Jun 30 2022n/an/a

-US$31m

Mar 31 2022n/an/a

-US$35m

Dec 31 2021US$1mUS$260k

-US$30m

Sep 30 2021n/an/a

-US$25m

Jun 30 2021n/an/a

-US$22m

Mar 31 2021n/an/a

-US$10m

Dec 31 2020US$469kUS$250k

-US$9m

Sep 30 2020n/an/a

-US$9m

Jun 30 2020n/an/a

-US$8m

Mar 31 2020n/an/a

-US$8m

Dec 31 2019US$992kUS$250k

-US$7m

Sep 30 2019n/an/a

-US$7m

Jun 30 2019n/an/a

-US$7m

Mar 31 2019n/an/a

-US$7m

Dec 31 2018US$564kUS$250k

-US$7m

Sep 30 2018n/an/a

-US$7m

Jun 30 2018n/an/a

-US$7m

Mar 31 2018n/an/a

-US$7m

Dec 31 2017US$490kUS$232k

-US$6m

Compensazione vs Mercato: La retribuzione totale di Brian ($USD 1.74M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 2.18M ).

Compensazione vs guadagni: La retribuzione di Brian è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Brian Sullivan (62 yo)

12.8yrs

Mandato

US$1,738,115

Compensazione

Mr. Brian F. Sullivan is the Co-Founder of Celcuity Inc. and has been its Chairman and Chief Executive Officer since 2012 and served as its Chief Financial Officer. Mr. Sullivan Co-founded Entegris, Inc. i...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Brian Sullivan
Co-Founder12.8yrsUS$1.74m8.12%
$ 39.8m
Lance Laing
Co-Founder12.8yrsUS$1.48m3.37%
$ 16.5m
Vicky Hahne
Chief Financial Officer7.3yrsUS$898.74k0.050%
$ 244.8k
Brent Eilefson
General Counselless than a yearNessun datoNessun dato
John MacDonald
Senior Vice President of R&D3.8yrsNessun datoNessun dato
Sheri Smith
Acting Head of Clinical Operations3.8yrsNessun datoNessun dato
Igor Gorbatchevsky
Chief Medical Officer2.7yrsNessun datoNessun dato
Eldon Mayer
Chief Commercial Officerless than a yearNessun datoNessun dato
Charlotte Moser
Senior Vice President of Clinical Developmentless than a yearNessun datoNessun dato

3.8yrs

Durata media

62yo

Età media

Gestione esperta: Il team dirigenziale di CELC è considerato esperto (durata media dell'incarico 3.8 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Brian Sullivan
Co-Founder12.8yrsUS$1.74m8.12%
$ 39.8m
Lance Laing
Co-Founder12.8yrsUS$1.48m3.37%
$ 16.5m
Richard Nigon
Independent Director7.8yrsUS$87.50k0.27%
$ 1.3m
David Dalvey
Independent Director10.8yrsUS$87.50k0.025%
$ 123.0k
Leo Furcht
Independent Director5.5yrsUS$87.50k0.028%
$ 138.5k
Ronald McGlennen
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Edward Greeno
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Sara A. Hurvitz
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Carol Lange
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Benita Katzenellenbogen
Member of Scientific Advisory Boardno dataNessun datoNessun dato
John Katzenellenbogen
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Mothaffar Rimawi
Member of Scientific Advisory Board5.8yrsNessun datoNessun dato

9.3yrs

Durata media

66yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di CELC sono considerati esperti (durata media dell'incarico 9.3 anni).